Inter-organ crosstalk during development and progression of type 2 diabetes mellitus

G Xourafa, M Korbmacher, M Roden - Nature Reviews Endocrinology, 2024 - nature.com
Type 2 diabetes mellitus (T2DM) is characterized by tissue-specific insulin resistance and
pancreatic β-cell dysfunction, which result from the interplay of local abnormalities within …

Endocrine aspects of metabolic dysfunction associated steatotic liver disease (MASLD): Beyond insulin resistance

AL Hutchison, F Tavaglione, S Romeo, M Charlton - Journal of Hepatology, 2023 - Elsevier
While the links between metabolic dysfunction associated steatotic liver disease liver
disease (MASLD) and obesity, insulin resistance are widely appreciated, there are a host of …

Small intestinal bacterial overgrowth and non-alcoholic fatty liver disease: what do we know in 2023?

A Gudan, K Kozłowska-Petriczko, E Wunsch… - Nutrients, 2023 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease associated with the
pathological accumulation of lipids inside hepatocytes. Untreated NAFL can progress to non …

Nonalcoholic fatty liver disease: current therapies and future perspectives in drug delivery

I Domingues, IA Leclercq, A Beloqui - Journal of Controlled Release, 2023 - Elsevier
Nonalcoholic fatty liver disease (NAFLD) affects approximately 25% of the adult population
worldwide. This pathology can progress into end-stage liver disease with life-threatening …

Liver fat as risk factor of hepatic and cardiometabolic diseases

M Demir, SR Bornstein, CS Mantzoros… - Obesity …, 2023 - Wiley Online Library
Non‐alcoholic fatty liver disease (NAFLD) is a disorder characterized by excessive
accumulation of fat in the liver that can progress to liver inflammation (non‐alcoholic …

Exerkines and cardiometabolic benefits of exercise: from bench to clinic

L Jin, C Diaz-Canestro, Y Wang, MA Tse… - EMBO Molecular …, 2024 - embopress.org
Regular exercise has both immediate and long-lasting benefits on cardiometabolic health,
and has been recommended as a cornerstone of treatment in the management of diabetes …

The pan-PPAR agonist lanifibranor improves cardiometabolic health in patients with metabolic dysfunction-associated steatohepatitis

MP Cooreman, J Butler, RP Giugliano… - Nature …, 2024 - nature.com
Lanifibranor, a pan-PPAR agonist, improves liver histology in patients with metabolic
dysfunction-associated steatohepatitis (MASH), who have poor cardiometabolic health …

Role of steatotic liver disease in prediction and prevention of cardiometabolic diseases

N Stefan, A Lonardo, G Targher - Nature Reviews Gastroenterology & …, 2024 - nature.com
Role of steatotic liver disease in prediction and prevention of cardiometabolic diseases |
Nature Reviews Gastroenterology & Hepatology Skip to main content Thank you for visiting …

The association between regional adiposity, cognitive function, and dementia-related brain changes: a systematic review

E Boccara, S Golan, MS Beeri - Frontiers in Medicine, 2023 - frontiersin.org
Background Adiposity has been previously associated with cognitive impairment and
Alzheimer's disease and related disorders (ADRD). Body mass index (BMI) is the most …

Insulin resistance and metabolic flexibility as drivers of liver and cardiac disease in T2DM

S Colosimo, SK Mitra, T Chaudhury… - Diabetes Research and …, 2023 - Elsevier
Metabolic flexibility refers to the ability of tissues to adapt their use of energy sources
according to substrate availability and energy demands. This review aims to disentangle the …